{
 "PrintNo":"S5942","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-05-16T13:39:32.32548Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-05-16","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1227,"Name":"Julia Salazar","Short":"SALAZAR"}],
 "Title":"Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs",
 "Summary":"Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.",
 "LawSection":"Public Health Law","LawCode":"Add ยง277-a, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs",
 "SameAsPrintNo":"A8253-2019"
}